Eupraxia Pharmaceuticals Inc. (TSX:EPRX)
Canada · Delayed Price · Currency is CAD 10.75
+0.10 (0.94%)
May 1, 2026, 4:00 PM EST
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of CAD 661.16 million as of May 1, 2026. Its market cap has increased by 315.38% in one year.
Market Cap
661.16M
Enterprise Value
589.50M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
10.75
Market Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from 78.01M to 661.16M, an increase of 747.57%. That is a compound annual growth rate of 51.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 661.16M | 26.49% |
| Dec 31, 2025 | 522.69M | 225.34% |
| Dec 31, 2024 | 160.66M | 9.74% |
| Dec 29, 2023 | 146.40M | 85.76% |
| Dec 30, 2022 | 78.81M | 125.87% |
| Dec 31, 2021 | 34.89M | -55.27% |
| Mar 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 1.17B |
| Satellos Bioscience | 223.94M |
| Helix BioPharma | 151.23M |
| ME Therapeutics Holdings | 75.12M |
| Sharp Therapeutics | 63.16M |
| Sernova Biotherapeutics | 59.65M |
| NurExone Biologic | 50.63M |
| Medicenna Therapeutics | 49.22M |